Quotes 5-day view Delayed Nyse
06/29/2022
06/30/2022
07/01/2022
07/05/2022
07/06/2022
Date
214.11(c)
216.99(c)
215.05(c)
215.31(c)
215.555
Last
1 143 234
1 811 578
856 325
775 334
223 652
Volume
+0.90%
+1.35%
-0.89%
+0.12%
+0.11%
Change
Estimated financial data (e) (USD)
Sales 2022
14 619 M
-
-
Net income 2022
1 300 M
-
-
Net Debt 2022
10 349 M
-
-
P/E ratio 2022
31,9x
Yield 2022
-
Sales 2023
16 093 M
-
-
Net income 2023
1 579 M
-
-
Net Debt 2023
9 702 M
-
-
P/E ratio 2023
25,7x
Yield 2023
-
Capitalization
40 754 M
40 754 M
-
EV / Sales 2022
3,50x
EV / Sales 2023
3,14x
Nbr of Employees
82 000
Free-Float
73,3%
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical...
Ratings of Iqvia Holdings Inc.
All news about IQVIA HOLDINGS INC.
News in other languages on IQVIA HOLDINGS INC.
Analyst Recommendations on IQVIA HOLDINGS INC.
Chart IQVIA HOLDINGS INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends IQVIA HOLDINGS INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
20
Last Close Price
215,31 $
Average target price
262,39 $
Spread / Average Target
21,9%
Please enable JavaScript in your browser's settings to use dynamic charts.